Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023241 (
Legionella
)
6,990
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Legionella
pneumophila is a facultative intracellular pathogen that is an important cause of pneumonia. Although host factors that may predispose to acquisition of
Legionnaire's Disease
(LD) include comorbid illnesses (e.g., diabetes, chronic
lung disease
), age, male sex, and smoking, many individuals have no identifiable risk factors. Some studies suggest that genetic factors may enhance susceptibility to LD. In this chapter we discuss current techniques and scientific methods to identify genetic susceptibility factors. These genetic studies provide insight into the human immune response to intracellular pathogens and may improve strategies for treatment and vaccine development.
...
PMID:Human susceptibility to legionnaires' disease. 2315 Apr 19
Legionnaire's disease
(LD) is mainly reported in apparently immunocompetent patients. Among them, risk factors include chronic
lung disease
and smoking. However, LD is also well reported among immunocompromised patients, particularly those treated with anti-tumor necrosis factor alpha therapy, patients with hematological malignancy, and transplant patients. This article discusses the available data on immunity against
Legionella
spp, epidemiology, clinical presentation, diagnosis, and treatment of LD in immunocompromised patients.
...
PMID:Legionnaire's Disease in Compromised Hosts. 2815 72
Legionella
pneumophila is a facultative intracellular pathogen responsible for legionellosis, a severe
lung disease
in humans. This bacterium uses a type 4b secretion system to deliver various effector proteins into the cytoplasm of a eukaryotic target cell. Among those is the glucosyltransferase Lgt1. This effector modifies serine-53 in eukaryotic elongation factor 1A (eEF1A) by mono-O-glucosylation. Modification of eEF1A results in inhibition of protein synthesis and death of the eukaryotic cell, processes which are thought to contribute to Legionella infection. Here we describe a protocol for isolation of the glucosyltransferase Lgt1 from L. pneumophila culture followed by assaying its enzymatic activity using
14
C-UDP-glucose autoradiography.
...
PMID:Purification and Analysis of Effector Glucosyltransferase Lgt1 from Legionella pneumophila. 3069 99
<< Previous
1
2
3